LevoCept
Description: LevoCept is an IUD product. It consists of a flexible shape memory frame and a reservoir containing 52 mg of levonorgestrel.
Product Details
Regimen:
Dose: 52 mg
Active Pharmaceutical Ingredient (API):
Status Details
Status Details: - Phase 2 clinical study to evaluate the effectiveness, safety and tolerability of LevoCept began in the US in November, 2016 with estimated study completion in April, 2021.
- Phase 2 clinical study to evaluate the effectiveness, safety and tolerability of LevoCept began in the US in November, 2016 with estimated study completion in April, 2021.
Additional Information
References: Contramed website: https://www.contramed.com/levocept/levocept-overview/
Clinicaltrials.gov Identified NCT02882191
Contramed website: https://www.contramed.com/levocept/levocept-overview/
Clinicaltrials.gov Identified NCT02882191